SPDR S&P Biotech ETF (NYSEARCA:XBI – Get Free Report)’s share price crossed below its 200-day moving average during trading on Friday. The stock has a 200-day moving average of $143.36 and traded as low as $139.87. SPDR S&P Biotech ETF shares last traded at $140.18, with a volume of 9,431,927 shares changing hands.
SPDR S&P Biotech ETF Price Performance
The business’s 50-day moving average price is $152.71 and its two-hundred day moving average price is $143.36. The firm has a market cap of $9.36 billion, a price-to-earnings ratio of 20.64 and a beta of 0.87.
Institutional Investors Weigh In On SPDR S&P Biotech ETF
Several hedge funds and other institutional investors have recently modified their holdings of the stock. Bank of America Corp DE grew its stake in SPDR S&P Biotech ETF by 13.3% in the first quarter. Bank of America Corp DE now owns 14,518,027 shares of the exchange traded fund’s stock worth $1,854,388,000 after purchasing an additional 1,700,851 shares in the last quarter. Northwestern Mutual Wealth Management Co. raised its stake in SPDR S&P Biotech ETF by 145.7% during the second quarter. Northwestern Mutual Wealth Management Co. now owns 314,224 shares of the exchange traded fund’s stock valued at $49,726,000 after buying an additional 186,314 shares in the last quarter. Annex Advisory Services LLC raised its stake in SPDR S&P Biotech ETF by 4.6% during the third quarter. Annex Advisory Services LLC now owns 266,485 shares of the exchange traded fund’s stock valued at $42,019,000 after buying an additional 11,723 shares in the last quarter. Whittier Trust Co. raised its stake in SPDR S&P Biotech ETF by 0.5% during the third quarter. Whittier Trust Co. now owns 259,132 shares of the exchange traded fund’s stock valued at $39,847,000 after buying an additional 1,379 shares in the last quarter. Finally, Group One Trading LLC bought a new position in SPDR S&P Biotech ETF during the 3rd quarter worth approximately $34,617,000.
About SPDR S&P Biotech ETF
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.
Further Reading
- Five stocks we like better than SPDR S&P Biotech ETF
- Survey Reveals: How Much Would People Pay for Ribeye Before Giving It Up? [2026]
- If NVIDIA Tightens Its Wallet, These 3 Stocks Could Feel It
- 3 Dividend ETFs Offering Steadier Footing in a Shaky Market
- Lazard’s New ETF Targets Monthly Income With Junk Bonds
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.
